Stay updated on Grapiprant and Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Grapiprant and Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Grapiprant and Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.
    Difference
    3%
    Check dated 2024-12-07T16:07:54.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Several key resources related to genetics and rare diseases have been removed, including links to MedlinePlus and NIH, which may impact access to important health information.
    Difference
    5%
    Check dated 2024-11-23T04:36:11.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding several new resources related to genetics, lung cancer, and drug information, while removing the previous version 2.12.1.
    Difference
    5%
    Check dated 2024-11-08T18:13:39.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.1%
    Check dated 2024-11-01T10:31:35.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential improvements or features.
    Difference
    0.2%
    Check dated 2024-10-25T00:31:01.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-10-03T04:44:39.000Z thumbnail image

Stay in the know with updates to Grapiprant and Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Grapiprant and Pembrolizumab in NSCLC Clinical Trial page.